ZeroStack Corp. (ZSTK) 股票分析

公司概述

ZeroStack Corp. operates primarily through its subsidiary, Phatebo GmbH, which focuses on pharmaceutical distribution within the German market, serving the broader Financial Services sector under the specific industry of Asset Management. The company manages distinct operational segments comprising Commercial & Wholesale activities alongside Digital Assets, distributing a diverse range of pharmaceutical goods and medical products to address various health indications. Currently, the organization employs a workforce of 21 individuals and holds a total market capitalization of $11.98M, generating annual revenue over the trailing twelve months of $35.68M. These valuation and revenue figures indicate a small-cap entity operating with a modest revenue base relative to its market capitalization, suggesting a business structure where market pricing significantly exceeds current sales generation.

财务健康

Over the trailing twelve months, the company reported a revenue of $35.68M, yet recorded a net income of $-115,410,000, resulting in an EBITDA of $-11,027,000. The substantial disparity between the positive revenue figure and the deeply negative net income reveals a cost structure characterized by significant non-operating expenses or losses that far outweigh the gross profits generated from core business activities. The free cash flow stands at $-5,176,000, indicating that the company is currently burning cash, which limits its financial flexibility and ability to fund organic growth or return capital without external financing. The gross margin is recorded at 4.6%, while the operating margin is negative at -54.8% and the profit margin is effectively 0.0%, highlighting a business model where operating costs severely erode gross profits before reaching the bottom line. In terms of liquidity and leverage, the company holds $5.60M in cash against total debt of $53.93M, resulting in a debt-to-equity ratio of 76.44, which characterizes a highly leveraged balance sheet reliant on substantial debt obligations. The current ratio is 1.01, suggesting that the company's short-term assets are only marginally sufficient to cover its short-term liabilities, posing potential liquidity risks in a tightening credit environment. Furthermore, the return on equity is -307.5% and the return on assets is -9.3%, metrics that reveal management is currently destroying shareholder value and utilizing assets inefficiently to generate positive returns.

估值评估

The P/E Ratio (TTM) and Forward P/E are both listed as N/A due to the company's negative earnings, which implies that traditional earnings-based valuation metrics cannot be applied to assess the company's current profitability trajectory. The price-to-book ratio is 0.07, indicating that the market values the company at a fraction of its book value, suggesting the market assigns a heavy discount to its tangible assets likely due to the negative equity and operational losses. The price-to-sales ratio stands at 0.34, while the EV/EBITDA is -5.47; these alternative valuation metrics suggest that investors are pricing the stock based on revenue multiples rather than earnings, reflecting the high risk associated with the negative EBITDA multiple. The stock has traded between a 52-week low of $4.78 and a 52-week high of $47.00, a range that demonstrates extreme volatility within a single year. With a beta of 2.01, the stock exhibits price volatility that is more than twice as high as the broader market, meaning price movements are amplified significantly relative to market indices.

Growth & Income

Revenue growth year-over-year is 22.3%, whereas earnings growth is N/A due to the persistent net losses, indicating that top-line expansion is not yet translating into bottom-line profitability. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means all available earnings are theoretically available for reinvestment, although the current losses preclude actual dividend distribution. Since the company is a non-dividend payer and currently unprofitable, it reinvests any potential earnings or capital into its business operations in an attempt to achieve future profitability rather than returning cash to shareholders. Overall, the growth and income profile presents a high-risk scenario where significant revenue expansion coexists with deep losses and a lack of cash distribution, relying entirely on future operational improvements to alter the current financial trajectory.